Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Mean values with standard deviations averaged over gestational age. by Irina Sidorenko (99951)

Subjects:

Gut and nasal microbiome features have significantly different pairwise distance distributions compared to null expectation. by Holly Kristin Arnold (14204655)

Occupational stress proportion by departments and COVID-19 patient care. by Phu Dinh Vu (19429477)

Subjects:

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

Subjects:

Clinical significance test. by Olive M. Fast (6655304)

Clinically significant associations with quantitative results of MMP-9 point-of-care test. by You Hyun Lee (9111030)

“…<p>Clinically significant associations with quantitative results of MMP-9 point-of-care test.…”

Clinically significant associations with semiquantitative results of MMP-9 point-of-care test. by You Hyun Lee (9111030)

“…<p>Clinically significant associations with semiquantitative results of MMP-9 point-of-care test.…”

NN analysis to assign the importance of variables. by Sulmaz Ghahramani (3387635)

Intention to treat (ITT) means (standard deviations) for outcome and process measures for all participants in the ACT (n = 52) and waitlist control (n = 46) groups. by Arianna Prudenzi (12436789)

Subjects:

Mean trends of ANC provision at the Sidama region’s public hospitals in Ethiopia. by Zemenu Yohannes Kassa (9304387)

Subjects:

Uni- and multivariate analysis of risk factors for unfavorable clinical outcomes in patients with brain abscess. by Yun Suk Cho (8956628)

Subjects:

Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (sign... by Mobina Faqani (22783963)

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Data_Sheet_1_Efficient Assay and Marker Significance of NAD+ in Human Blood.pdf by Natalia V. Balashova (12564634)

“…In patients with demyelinating neurological diseases (n = 10, 18–55 years old), the NAD⁺ levels significantly (p < 0.0001) decrease (to 14 μM, min 13, max 16), compared to the control group. …”

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... by Mobina Faqani (22783963)

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

Mean decrease Gini score by Tweet and user characteristics. by Gray Babbs (16648894)